Structure |
Chemical Name |
CAS |
MF |
|
Canagliflozin Impurity 9 |
|
|
|
Clopidogrel Impurity 14 |
|
C15H14ClNO2S |
|
Febuxostat Impurity 53 |
|
|
|
Cefodizime Impurity C |
|
|
|
Riociguat IMpurtiy F |
|
|
|
Nifedipine impurity 10 |
10323-98-5 |
C13H13NO3 |
|
Cefminox Sodium impurity E |
|
|
|
Clindamycin Impurity D |
|
|
|
Fasudil iMpurity C |
|
|
|
Cefminox Impurity D |
|
|
|
SORAFENIB N-OXIDE |
583840-03-3 |
C21H16ClF3N4O4 |
|
CHLORHEXIDENE DIACETATE IMPURITY A |
152504-08-0 |
C16H24ClN9 |
|
Ipragliflozin Impurity 6 |
|
|
|
Ibrutinib Impurity 27 |
2031255-26-0 |
C26H28N6O3 |
|
Clopidogrel Impurity 59 |
1122047-98-6 |
C25H26ClNO6S |
|
Ozagrel Impurity B |
|
|
|
Ceftriaxone Sodium impurity F |
|
|
|
(R)-5-(2-fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-3-(2-(2-oxopyrrolidin-1-yl)-2-phenylethyl)pyrimidine-2,4(1H,3H)-dione |
2248628-93-3 |
C32H28F5N3O4 |
|
Famotidine EP Impurity I HCl |
|
C8H15N7O2S3 |
|
替扎尼定EP雜質(zhì)C |
1147548-83-1 |
C16H14Cl2N10S2 |
|
nicergoline impurity Q |
|
|
|
Loratadine Impurity 19 |
79779-58-1 |
C22H24N2O2 |
|
(Z)-2-chloro-3-hydroxyacrylaldehyde |
50704-42-2 |
C3H3ClO2 |
|
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4''-fluoro-[1,1''-biphenyl]-4-yl)-1-methylpiperidine hydrochloride |
|
|
|
Ticagrelor Related Compound 39 |
|
|
|
Erlotinib Impurity 32 |
|
|
|
Pramipexole Impurity 36 |
|
|
|
Teneligliptin Impurity 3 |
|
|
|
Erlotinib Hydrochloride iMpurity 52 |
|
|
|
Ornidazole Impurity J |
742020-47-9 |
C7H12N4O3 |
|
Androstan-17-one,2,3-epoxy-16-(1-pyrrolidinyl) |
159325-45-8 |
C23H35NO2 |
|
(2b,3a,16b,17b)-2,16-Bispiperidino-3,17-diacetoxy-5-androstane |
13529-31-2 |
C33H54N2O4 |
|
Palbociclib Impurity 59 |
1430196-98-7 |
C14H20N4O4 |
|
Landiolol impurity Z |
|
|
|
Vitamin K1 Impurity 1 |
19274-66-9 |
C31H46O2 |
|
Teneligliptin Impurity 13 |
|
|
|
Ceftazidime EP Impurity D |
73547-69-0 |
C45H44N6O7S2 |
|
Nicergoline EP Impurity G |
57935-65-6 |
C23H24BrN3O2 |
|
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
|
2-Pyrrolidinecarbonitrile, 1-(2-aminoacetyl)-, hydrochloride (1:1), (2S)- |
913980-23-1 |
C7H12ClN3O |
|
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
|
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
|
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine |
127017-42-9 |
C21H25NO4 |
|
Methylprednisolone Impurity 21 |
150899-33-5 |
C22H28O4 |
|
Epinephrine Impurity 7 |
62322-82-1 |
C9H11NO3 |
|
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
Fesoterodine Impurity 14 |
|
|
|
Dexamethasone EP impurities E |
|
|
|
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
|
Empagliflozin Impurity 57(R,R) |
|
|
|
Aripiprazole peroxide degradation Impurity (MW:303Da) |
|
|
|
Pramipexole Impurity Reference |
|
|
|
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+ |
|
|
|
3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester |
100688-45-7 |
C13H14O4 |
|
8-cyclopentyl-6-(1-hydroxyethyl)-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one |
1376615-91-6 |
C24H31N7O2 |
|
Plerixafor Impurity A |
|
|
|
Ceftazidime Impurity G |
138829-73-9 |
C11H14N4O5S |
|
Vonoprazan Impurity 6 |
|
|
|
Umeclidinium Bromide Impurity 4 |
869112-31-2 |
C22H28BrNO2 |
|
Acetaminophen Impurity 14 |
1991204-56-8 |
C16H18N2O2 |
|
Ketoconazole Impurity 7 |
172032-21-2 |
C11H12Cl2O3 |
|
Rosuvastatin Impurity 59 |
|
|
|
Losartan Impurity 12 |
727718-93-6 |
C22H22ClN9 |
|
benzyl (2S)-2-amino-3-(4-methanesulfonylphenyl)propanoate hydrochloride |
1865726-28-8 |
C17H19NO4S |
|
Glycopyrrolate Impurity 12 |
857353-41-4 |
C13H14O3 |
|
(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
4660-26-8 |
C22H22N2O8 |
|
Regorafenib Impurity 38 |
|
|
|
Cefazolin Impurity 28 |
|
|
|
Vonoprazan Impurity 57 |
|
|
|
Tafluprost Impurity 9 |
2099033-66-4 |
C27H41NO8 |
|
2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-5-hydroxy-7,8-dimethoxy- |
2253977-80-7 |
C27H36N2O6 |
|
Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester |
1187954-56-8 |
C33H41NO4 |
|
N-[2-(methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]-Adenosine 5''-(hydrogen P-1H-imidazol-1-ylphosphonate) |
1054332-15-8 |
C19H25F3N7O6PS2 |
|
N-[5-(4-Bromophenyl)-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N''-propyl-sulfamide |
2211059-00-4 |
C19H21BrN6O4S |
|
Isomer 1 of Tazobactam Impurity 3 |
|
|
|
Ceftiofur USP Impurity I |
|
|
|
Cephalexin Degradation Impurity A |
|
|
|
Pregabalin-8687(mixture of 4 isomers) |
|
|
|
7-(2-chloropropanoyl)-5H-chromeno[2,3-b]pyridin-5-one |
|
|
|
1-(5H-chromeno[2,3-b]pyridin-7-yl)-2-methoxypropan-1-one |
|
|
|
(E)-4-chloro-6-(3-(2,4-difluorophenyl)-4-(1H-1,2,4-triazol-1-yl)but-3-en-2-yl)-5-fluoropyrimidine |
|
|
|
Dolutegravir Impurity C |
1802141-49-6 |
C22H23F2N3O5 |
|
Dapoxetine Impurity 68 |
119357-48-1 |
C19H18O |
|
Tobramycin Impurity |
74501-86-3 |
C18H35N5O8 |
|
Peramivir Impurity 24 |
|
|
|
2-CHLORO-6-AMINO-9-(2',3',5'-TRI-O-ACETYL--D-RIBOFURANOSYL)PURINE |
79999-39-6 |
C16H18ClN5O7 |
|
Sugammadex sodium Impurity 46 |
|
|
|
Tenofovir Impurity 103 |
|
|
|
Cabozantinib impurity 44 |
|
|
|
Cabozantinib impurity 40 |
|
|
|
Cabozantinib impurity 74 |
|
|
|
Doxofylline Impurity 25 |
|
|
|
Dapoxetine impurity 62 |
|
|
|
Dapoxetine impurity 56 |
|
|
|
D-(-)-N-(2,4-diamino-6-pteridinyl(dimethylamino)benzoyl)glutaminsure |
51865-79-3 |
C20H22N8O5 |
|
Bimatoprost Impurity 11 |
|
|
|
Bimatoprost Impurity 9 |
|
|
|
Dolutegravir Impurity 18 |
|
|
|
PeraMpanel |
380918-53-6 |
C23H15N3O |
|
Lenvatinib Impurity 33 |
|
|